Background:
S-Acylation, a protein lipidation process that is essential for neuronal functions, is catalyzed by zDHHC S-acyltransferases.Results: The ankyrin repeat (AR) domains of zDHHC17 and zDHHC13 recognize a novel unstructured peptide sequence in several unrelated proteins.Conclusion: Several proteins have independently acquired similar short peptide sequences for zDHHC17/13 binding.Significance: This is the first study to identify a motif recognized by AR-containing S-acyltransferases.
The molecular machinery that catalyzes S-acylation reactions at the Golgi comprises zDHHC enzymes with major differences in substrate affinity and S-acylation activity. It is proposed that the coexistence of these two groups of enzymes in cells is important to allow the Golgi S-acylation machinery to modify a wide and diverse set of substrates.
The discovery of the zDHHC family of S-acyltransferase enzymes has been one of the major breakthroughs in the S-acylation field. Now, more than a decade since their discovery, major questions centre on profiling the substrates of individual zDHHC enzymes (there are 24 ZDHHC genes and several hundred S-acylated proteins), defining the mechanisms of enzyme-substrate specificity and unravelling the importance of this enzyme family for cellular physiology and pathology.
Palmitoylation, the attachment of palmitate and other fatty acids on to cysteine residues, is a common post-translational modification of both integral and peripheral membrane proteins. Dynamic palmitoylation controls the intracellular distribution of peripheral membrane proteins by regulating membrane-cytosol exchange and/or by modifying the flux of the proteins through vesicular transport systems.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.